Nykredit A/S’s Tango Therapeutics TNGX Stock Holding History

Nykredit A/S’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.4K	Buy	+844	New	+$20.9K	﹤0.01%	1656

Other funds holding TNGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TGI

TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nykredit A/S's TNGX Position: Q2 2026 in Review

Nykredit A/S opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 844 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #1656 among its holdings.

145 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Nykredit A/S held 844 shares of Tango Therapeutics worth $26.4K as of Q2 2026.
Tango Therapeutics was a new Nykredit A/S position in Q2 2026.
Tango Therapeutics made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1656 holding.
145 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.